How Can We Return to Honest, Unbiased Healthcare?

Dr. Harvey Risch is a Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine. Dr. Risch received his MD degree from the University of California San Diego and his Ph.D., in mathematical modeling of infectious epidemics, from the University of Chicago. After serving as a postdoctoral fellow in epidemiology at the University of Washington, Dr. Risch was a faculty member in epidemiology and biostatistics at the University of Toronto before coming to Yale. Dr. Risch’s research interests are in the areas of cancer etiology, prevention, and early diagnosis, and epidemiologic methods. He is especially interested in the effects of reproductive factors, diet, genetic predisposition, histopathologic factors, occupational/environmental/medication exposures, infection, and immune functioning in cancer etiology. His major research projects have included studies of ovarian cancer, pancreas cancer, lung cancer, bladder cancer, esophageal and stomach cancer, and of cancers related to the usage of oral contraceptives and non-contraceptive estrogens. Dr. Risch is Associate Editor of the Journal of the National Cancer Institute, Editor of the International Journal of Cancer, and for six years was a Member of the Board of Editors, of the American Journal of Epidemiology. Dr. Risch is an author of more than 400 original peer-reviewed research publications in the medical literature and those research papers have been cited by other scientific publications more than 50,000 times. Dr. Risch has an h-index of 107 and is a Member of the Connecticut Academy of Sciences and Engineering.

The Science Doesn’t Add Up

Coming from a very distinguished background in science, Dr. Risch admits to being “sidetracked” into cancer research for the last 40 years. After becoming a member of the Connecticut Academy of Science and Engineering, the Academy formed a committee dedicated to finding ways to help Connecticut get out of lockdown. Dr. Risch then began by analyzing studies of early outpatient treatments. By April 2020, hydroxychloroquine had been successfully used by an increasing number of doctors. The Zelenko protocol, which includes azithromycin and zinc, was also shown to be very effective for patients in the early stages of COVID.

Dr. Risch then went on to conduct a literature review of the use of Hydroxychloroquine and Remdesevir based on many research papers. It became very clear to him that hydroxychloroquine was beneficial in preventing hospitalization and mortality for those in the early stages of COVID. Dr. Risch published his literature review in the American Journal of Epidemiology. The review was very newsworthy and sparked much attention.

Soon, however, his review started being misquoted. At first, it seemed like honest mistakes, until the misquoting became systematic, pushing stories of already hospitalized patients for whom hydroxychloroquine was not working.

Dr. Risch explains the problem with these claims by pointing out that his review found that hydroxychloroquine was effective in outpatients in the early stages of COVID (days 5 or 6), not already hospitalized patients. The reason for this was very simple: most patients already hospitalized suffered from acute respiratory distress syndrome pneumonia, a condition with a completely different set of treatments and management compared to the outpatient viral disease.

The Role of The Wellness Company in Combatting Medical Corruption

A major learning moment, Dr. Risch explains, having joined The Wellness Company, was realizing how much those in the medical profession have been desensitized to corruption over the last decade.

First,  insurance companies came, saying what conditions and procedures they would or would not cover. Then, larger medical practices and hospitals started buying out the smaller, individual practices. The large practices then began telling the individual practitioners what they could or could not do. Now, Dr. Risch explains, hedge funds are buying up small practices as well. Now, instead of putting the health and well-being of the patient first, the overall goal is money. Treating healthcare as a commodity instead of a professional service biases the decisions that doctors make and restricts what they are allowed to say. They no longer can provide honest, unburdened, unbiased, and unrestricted care to their patients.

The sad truth of it is, many doctors have no way to extricate themselves from the growing system of Big Pharma because they have no plan b, no way to return to independent practice without being subject to blacklisting. Often, practice management can restrict doctors to only refer in-house, not to outside, individually practicing doctors that they would honestly recommend.

True, honest healthcare, is a combination of objective science partnered with experience that aims to achieve the best possible treatments for patients. That’s where The Wellness Company comes in. The Wellness Company offers patients the opportunity to receive honest, unbiased healthcare, without the pressure of Big Pharma.

Learn More:

The Wellness Company

Spike Recovery

Wellness Membership

Freedom From Pharma

Use code DAILYCLOUT for 10% off

Subscribe to DailyClout so you never miss an update!

• Email*

Δ

Kate Hildreth is the Creative Director at DailyClout and a contributor on the DailyClout Network. She has a degree in English and Writing Studies with a focus in Philosophy.  Gettr     Twitter     Substack